biowaiver for higher strength [Regulatives / Guidelines]

posted by wienui  – Germany/Oman, 2022-02-01 10:12 (839 d 00:19 ago) – Posting: # 22768
Views: 2,242

(edited by wienui on 2022-02-01 15:29)

Hi John,

❝ Based on the above, can I file a biowaiver for the higher strength test product so I don't have to run a PK BE study?


Are both strengths (low & high) follow the following EMA 5% & exceients rule?

EMA :
Amount of API must be < 5% of tablet core weight, and
Amounts of excipients are same per strength, or
Only the amount of a filler is changed to account for changes in API weight.

Cheers,
Osama

Complete thread:

UA Flag
Activity
 Admin contact
23,033 posts in 4,835 threads, 1,643 registered users;
50 visitors (0 registered, 50 guests [including 11 identified bots]).
Forum time: 11:32 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5